Mr. Naini joined Frazier Healthcare Partners in 1991 and has served on the firm’s management committee and led its Growth Buyout practice since 1995. Under his leadership, the team has successfully raised over $4 billion of limited partner capital for eleven investment vehicles and has realized over $4 billion in exits.
During his 27-year tenure with the firm, he has been responsible for successful investments in Aspen Education Group (acquired by Bain Capital) where he served as chairman, CHG Healthcare (acquired by JW Childs), Priority Solutions International (acquired by Thermo Fisher NASDAQ: TMO), Bravo Health (acquired by HealthSpring NYSE: HS), Laboratory Supply Company (acquired by McKesson NYSE: MCK), and DSI Renal (merged with U.S. Renal). Mr. Naini currently serves on the board of directors of Northfield Medical, Solis Mammography, and Alteon Health.
Prior to joining Frazier, he worked at Goldman Sachs & Co. in New York.
New York University Stern School of Business (M.B.A)
University of Pennsylvania (B.A)